| C-2 |
DNA | 50 |
HepG2 |
19 nM |
| 2013 |
Bioorganic & Medicinal Chemistry Letters |
AptaNexus |
| C-2 |
DNA | 95 |
Hepatoma HepG2 cells, Human |
19 nM source Kd |
| |
doi:10.1016/j.bmcl.2013.01.040 |
UTexas |
| C-1 |
DNA | 50 |
HepG2 |
20 nM |
| 2013 |
Bioorganic & Medicinal Chemistry Letters |
AptaNexus |
| C-1 |
DNA | 95 |
Hepatoma HepG2 cells, Human |
20 nM source Kd |
| |
doi:10.1016/j.bmcl.2013.01.040 |
UTexas |
| B-2 |
DNA | 50 |
HepG2 |
27 nM |
| 2013 |
Bioorganic & Medicinal Chemistry Letters |
AptaNexus |
| B-2 |
DNA | 95 |
Hepatoma HepG2 cells, Human |
27 nM source Kd |
| |
doi:10.1016/j.bmcl.2013.01.040 |
UTexas |
| C-3 |
DNA | 50 |
HepG2 |
50 nM |
| 2013 |
Bioorganic & Medicinal Chemistry Letters |
AptaNexus |
| C-3 |
DNA | 95 |
Hepatoma HepG2 cells, Human |
50 nM source Kd |
| |
doi:10.1016/j.bmcl.2013.01.040 |
UTexas |
| E-1 |
DNA | 50 |
HepG2 |
64 nM |
| 2013 |
Bioorganic & Medicinal Chemistry Letters |
AptaNexus |
| JHIT2 |
DNA | 25 |
HepG2 |
64 nM |
| 2015 |
PLoS ONE |
AptaNexus |
| E-1 |
DNA | 95 |
Hepatoma HepG2 cells, Human |
64 nM source Kd |
| |
doi:10.1016/j.bmcl.2013.01.040 |
UTexas |
| HA09 |
DNA | 80 |
Human-derived hepatoma cell line HepG2 |
104 nM source Kd |
| |
doi:10.1093/abbs/gmt130 |
UTexas |
| B-1 |
DNA | 50 |
HepG2 |
111 nM |
| 2013 |
Bioorganic & Medicinal Chemistry Letters |
AptaNexus |
| B-1 |
DNA | 95 |
Hepatoma HepG2 cells, Human |
111 nM source Kd |
| |
doi:10.1016/j.bmcl.2013.01.040 |
UTexas |
| C-4 |
DNA | 50 |
HepG2 |
141 nM |
| 2013 |
Bioorganic & Medicinal Chemistry Letters |
AptaNexus |
| C-4 |
DNA | 95 |
Hepatoma HepG2 cells, Human |
141 nM source Kd |
| |
doi:10.1016/j.bmcl.2013.01.040 |
UTexas |
| G-1 |
DNA | 50 |
HepG2 |
153 nM |
| 2013 |
Bioorganic & Medicinal Chemistry Letters |
AptaNexus |
| G-1 |
DNA | 95 |
Hepatoma HepG2 cells, Human |
153 nM source Kd |
| |
doi:10.1016/j.bmcl.2013.01.040 |
UTexas |
| D-1 |
DNA | 50 |
HepG2 |
195 nM |
| 2013 |
Bioorganic & Medicinal Chemistry Letters |
AptaNexus |
| D-1 |
DNA | 95 |
Hepatoma HepG2 cells, Human |
195 nM source Kd |
| |
doi:10.1016/j.bmcl.2013.01.040 |
UTexas |
| JHIT1 |
DNA | 25 |
HepG2 |
207 nM |
| 2015 |
PLoS ONE |
AptaNexus |
| A-2 |
DNA | 50 |
HepG2 |
214 nM |
| 2013 |
Bioorganic & Medicinal Chemistry Letters |
AptaNexus |
| A-2 |
DNA | 95 |
Hepatoma HepG2 cells, Human |
214 nM source Kd |
| |
doi:10.1016/j.bmcl.2013.01.040 |
UTexas |
| JHIT6 |
DNA | 25 |
HepG2 |
249 nM |
| 2015 |
PLoS ONE |
AptaNexus |
| JHIT3 |
DNA | 25 |
HepG2 |
272 nM |
| 2015 |
PLoS ONE |
AptaNexus |
| JHIT7 |
DNA | 25 |
HepG2 |
289 nM |
| 2015 |
PLoS ONE |
AptaNexus |
| HCA#3 |
DNA | 76 |
HepG2 |
305 nM |
| 2016 |
PLoS ONE |
AptaNexus |
| JHIT5 |
DNA | 25 |
HepG2 |
334 nM |
| 2015 |
PLoS ONE |
AptaNexus |
| JHIT4 |
DNA | 25 |
HepG2 |
349 nM |
| 2015 |
PLoS ONE |
AptaNexus |
| F-1 |
DNA | 50 |
HepG2 |
370 nM |
| 2013 |
Bioorganic & Medicinal Chemistry Letters |
AptaNexus |
| F-1 |
DNA | 95 |
Hepatoma HepG2 cells, Human |
370 nM source Kd |
| |
doi:10.1016/j.bmcl.2013.01.040 |
UTexas |
| A-1 |
DNA | 50 |
HepG2 |
450 nM |
| 2013 |
Bioorganic & Medicinal Chemistry Letters |
AptaNexus |
| A-1 |
DNA | 95 |
Hepatoma HepG2 cells, Human |
450 nM source Kd |
| |
doi:10.1016/j.bmcl.2013.01.040 |
UTexas |